Gene and Cell Therapy Workshop
Program Agenda:
- Manufacturing challenges for the commercialization of cell and gene Therapy Products
- Risk-based approach for clinical trials of Advanced Therapy Medicinal Products (ATMP)
- FDA regulation on biologics including cell and gene therapy products and clinical consideration on treatment of serious conditions with unmet medical needs
- China: Update on National Medical Product Administration (NMPA) Regulation Reform
- Logistics challenges and solutions for cell and gene therapy trials
- Innovative reimbursement models for CAR-T and gene therapies to translate regulatory approval into reimbursement
- Doctor’s view on how to overcome the bottle-neck in cell and gene therapy
You can view the detailed program here.
Register here: https://explore.parexel.com/l/563702/2019-09-09/7vrm4q